Teus van Laar

9.4k total citations · 2 hit papers
183 papers, 5.6k citations indexed

About

Teus van Laar is a scholar working on Neurology, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, Teus van Laar has authored 183 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Neurology, 38 papers in Cognitive Neuroscience and 24 papers in Cellular and Molecular Neuroscience. Recurrent topics in Teus van Laar's work include Parkinson's Disease Mechanisms and Treatments (134 papers), Neurological disorders and treatments (86 papers) and Botulinum Toxin and Related Neurological Disorders (33 papers). Teus van Laar is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (134 papers), Neurological disorders and treatments (86 papers) and Botulinum Toxin and Related Neurological Disorders (33 papers). Teus van Laar collaborates with scholars based in Netherlands, United States and United Kingdom. Teus van Laar's co-authors include Günther Deuschl, Werner Poewe, Cees Neef, Robbert W. K. Borgemeester, Peter Paul De Deyn, Peter C.G. Nijssen, Anne Marthe Meppelink, P. Richard Schuurman, Dag Aarsland and Ben Schmand and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Teus van Laar

176 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rivastigmine for Dementia Associated with Parkinson's Disease

2004 793 citations Teus van Laar et al. profile →
Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial

2012 513 citations Teus van Laar, Michiel J. Staal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Teus van Laar Netherlands	39	4.2k	1.2k	904	716	491	183	5.6k
Miguel Coelho Portugal	33	4.0k 1.0×	1.4k 1.1×	706 0.8×	688 1.0×	434 0.9×	103	5.3k
Hubert H. Fernandez United States	43	4.6k 1.1×	1.5k 1.2×	622 0.7×	867 1.2×	515 1.0×	225	6.0k
Hubert H. Fernandez United States	39	4.3k 1.0×	1.6k 1.3×	787 0.9×	946 1.3×	634 1.3×	107	6.1k
Tanya Simuni United States	43	3.8k 0.9×	1.1k 0.9×	1.0k 1.1×	734 1.0×	567 1.2×	162	5.6k
Santiago Perez‐Lloret Argentina	36	3.1k 0.8×	1.0k 0.8×	788 0.9×	616 0.9×	291 0.6×	131	4.9k
Alison J. Yarnall United Kingdom	40	3.6k 0.9×	780 0.6×	916 1.0×	1.1k 1.5×	612 1.2×	111	5.5k
Kapil D. Sethi United States	43	5.3k 1.3×	1.7k 1.4×	1.0k 1.2×	889 1.2×	583 1.2×	149	7.1k
Mark Stacy United States	47	6.0k 1.4×	2.5k 2.0×	1.1k 1.2×	752 1.1×	443 0.9×	110	8.0k
Rob M.A. de Bie Netherlands	39	5.7k 1.4×	2.4k 2.0×	962 1.1×	615 0.9×	728 1.5×	146	6.9k
Félix Bermejo‐Pareja Spain	45	2.8k 0.7×	1.4k 1.2×	675 0.7×	1.4k 1.9×	417 0.8×	155	6.1k

Countries citing papers authored by Teus van Laar

Since Specialization

Citations

This map shows the geographic impact of Teus van Laar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teus van Laar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teus van Laar more than expected).

Fields of papers citing papers by Teus van Laar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teus van Laar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teus van Laar. The network helps show where Teus van Laar may publish in the future.

Co-authorship network of co-authors of Teus van Laar

This figure shows the co-authorship network connecting the top 25 collaborators of Teus van Laar. A scholar is included among the top collaborators of Teus van Laar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teus van Laar. Teus van Laar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zee, Sygrid van der, et al.. (2025). Cholinergic Degeneration and Cognitive Function in Early GBA1‐Related Parkinson's Disease. Annals of Neurology. 98(2). 398–409.

Bohnen, Nicolaas I., Sygrid van der Zee, Kirk A. Frey, et al.. (2025). A multicenter longitudinal study of cholinergic subgroups in Parkinson disease. Nature Communications. 16(1). 5655–5655. 1 indexed citations

Weiß, Daniel, Wolfgang H. Jost, József Attila Szász, et al.. (2025). Levodopa–Entacapone–Carbidopa Intrajejunal Infusion in Advanced Parkinson's Disease – Interim Analysis of the ELEGANCE Study. Movement Disorders Clinical Practice. 12(8). 1075–1085. 5 indexed citations

Thijssen, Eva, Bert Tuk, Erica S. Klaassen, et al.. (2024). Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients. Clinical and Translational Science. 17(5). e13796–e13796. 5 indexed citations

Okkels, Niels, Michel J. Grothe, John‐Paul Taylor, et al.. (2024). Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes. Brain. 147(7). 2308–2324. 21 indexed citations

Zee, Sygrid van der, et al.. (2024). Cholinergic deficiency in Parkinson’s disease patients with visual hallucinations. Brain. 147(10). 3370–3378. 6 indexed citations

Harten, Barbera van, et al.. (2023). Timely referral for device-aided therapy in Parkinson's disease. Development of a screening tool. Parkinsonism & Related Disorders. 109. 105359–105359. 12 indexed citations

Zee, Sygrid van der, Giulia Carli, Jeffrey M. Boertien, et al.. (2023). Cholinergic innervation topography in GBA-associated de novo Parkinson’s disease patients. Brain. 147(3). 900–910. 11 indexed citations

Zee, Sygrid van der, et al.. (2023). Impaired facial emotion recognition in relation to social behaviours in de novo Parkinson's disease. Journal of Neuropsychology. 18(2). 205–216. 2 indexed citations

10.

Buskens, Erik, et al.. (2023). Patient Referral for Device‐Aided Therapies in Parkinson's Disease is Suboptimal; A Dutch Survey. Movement Disorders Clinical Practice. 10(12). 1821–1823. 2 indexed citations

11.

Eggink, Hendriekje, Martje E. van Egmond, D. L. Marinus Oterdoom, et al.. (2023). Deep brain stimulation in dystonia: The added value of neuropsychological assessments. Journal of Neuropsychology. 18(S1). 8–18. 1 indexed citations

12.

Laar, Teus van, et al.. (2022). STN-DBS electrode placement accuracy and motor improvement in Parkinson’s disease: systematic review and individual patient meta-analysis. Journal of Neurology Neurosurgery & Psychiatry. 94(3). 236–244. 11 indexed citations

13.

Phokaewvarangkul, Onanong, et al.. (2021). Early factors for predicting discontinuation to subcutaneous Apomorphine infusion in Parkinson's disease: A prospective analysis of the Thai Apomorphine Registry. Parkinsonism & Related Disorders. 91. 146–151. 11 indexed citations

14.

Maurits, Natasha M., et al.. (2021). Enhanced arm swing improves Parkinsonian gait with EEG power modulations resembling healthy gait. Parkinsonism & Related Disorders. 91. 96–101. 16 indexed citations

15.

Zee, Sygrid van der, Martijn L.T.M. Müller, Prabesh Kanel, Teus van Laar, & Nicolaas I. Bohnen. (2020). Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease. Movement Disorders. 36(3). 642–650. 64 indexed citations

16.

Sommer, Iris E., et al.. (2018). Successful treatment of intractable visual hallucinations with 5-HT_{_2A}antagonist ketanserin. BMJ Case Reports. 2018. bcr–2018. 5 indexed citations

17.

Borgemeester, Robbert W. K., Teus van Laar, & Marie L. A. Schuttelaar. (2018). Cutaneous adverse drug reaction after apomorphine infusion, possibly caused by a systemic type IV hypersensitivity reaction to sodium metabisulfite: Report of 2 cases. Contact Dermatitis. 79(5). 316–318. 8 indexed citations

18.

Chaudhuri, К. Ray, Roongroj Bhidayasiri, & Teus van Laar. (2016). Unmet needs in Parkinson's disease: New horizons in a changing landscape. Parkinsonism & Related Disorders. 33. S2–S8. 16 indexed citations

19.

Staal, Michiel J., et al.. (2014). Clinical Relevance of Pharmacological and Physiological Data in Intrathecal Baclofen Therapy. Archives of Physical Medicine and Rehabilitation. 95(11). 2199–2206. 30 indexed citations

20.

Nanlohy, Nening M., Charlotte H. S. B. van den Berg, Elly A. Hassink, et al.. (2008). HCV‐specific T‐cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance. Journal of Viral Hepatitis. 15(6). 409–420. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact